Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

MLA

Mateos, Beatriz, et al. “Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn’s Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.” Digestive Diseases (Basel, Switzerland), vol. 39, no. 1, 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1159/000508069.

APA

Mateos, B., Sáez-González, E., Moret, I., Hervás, D., Iborra, M., Cerrillo, E., Tortosa, L., Nos, P., & Beltrán, B. (2021). Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn’s Disease Response to Infliximab, as Assessed by Calprotectin Log Drop. Digestive Diseases (Basel, Switzerland), 39(1), 1–9. https://doi.org/10.1159/000508069

Chicago

Mateos, Beatriz, Esteban Sáez-González, Inés Moret, David Hervás, Marisa Iborra, Elena Cerrillo, Luis Tortosa, Pilar Nos, and Belén Beltrán. 2021. “Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn’s Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.” Digestive Diseases (Basel, Switzerland) 39 (1): 1–9. doi:10.1159/000508069.